AIR-Vaccination: AIR Institute promotes the design of sustainable vaccines with Generative AI

Artificial Intelligence is making an impact across many sectors; in healthcare, its benefits are proving invaluable for preventing diseases, enabling more accurate diagnoses, and carrying out thorough patient monitoring and follow-up. Combined with bioinformatics and high-performance computing, AI is fostering a new paradigm in vaccine design.

At AIR Institute, we are working on AIR-Vaccination, an innovative project developed with the support of the Institute for Business Competitiveness of the Regional Government of Castilla y León (ICE) and the European Regional Development Fund (ERDF). The aim is to accelerate and optimise the development of more effective, personalised, and sustainable vaccines through Artificial Intelligence methodologies and reverse vaccinology.

Reverse vaccinology is a novel methodology which, unlike traditional methods, starts directly with the analysis of the pathogen’s genome rather than cultivating or isolating it in the laboratory. This approach accelerates vaccine development by identifying specific epitopes more effectively, thereby reducing both animal testing and costs.

Through the advances made in AIR-Vaccination, we will be able to identify vaccine candidates with greater precision, efficiency, and personalisation, thus contributing to improved public health and positioning Castilla y León as a benchmark in biotechnology and innovation.